# Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)

> **NCT01883661** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Chaitanya Hospital, Pune** · enrollment: 15 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** BMMNC

## Key facts

- **NCT ID:** NCT01883661
- **Lead sponsor:** Chaitanya Hospital, Pune
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883661, "Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01883661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*